drugset / Trial / NCT03838328
Dose Effect of Tranexamic Acid on the Incidence of Deep Venous Thrombus in Cardiac Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
In recent years, the lysine analogs tranexamic acid (TXA) has gained wide use in cardiac surgery as a blood-sparing agent. However, the safety of the drug and its impact on overall outcomes of cardiac surgery remains debated. The current study evaluates the dose effect of TXA on the incidence of deep venous thrombus (DVT) in cardiac surgery with cardiopulmonary bypass. Also, the dose effect of TXA on bleeding and allogeneic transfusion is evaluated.
Timeline
- Start
- 2019-03-01
- Primary completion
- 2020-02-28
- Completion
- 2020-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 10 mg/kg | — |
| Subject | Tranexamic Acid | Small molecule | 15 mg/kg | — |
| Subject | Tranexamic Acid | Small molecule | 20 mg/kg | — |